Search Results 1-10 of 14777 for anti-TNF drugs

  1. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    Approved in 1998 for use in treating Crohn's disease and subsequently in 2005 for treating ulcerative colitis, anti-tumor necrosis factor (TNF) agents have ...

  2. Adalimumab (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab may be used alone or in combination with medicines (eg, methotrexate or ...

  3. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

    About this study. The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with ...

  4. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    Within the United States, four anti-TNF agents are currently approved for the treatment of IBD — infliximab, adalimumab, certolizumab pegol and golimumab.

  5. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents include increased ...

  6. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents include increased ...

  7. Adalimumab-Fkjp (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab-fkjp may be used alone or in combination with other medicines (eg, ...

  8. Crohn's disease - Diagnosis and treatment - Mayo Clinic

    Infliximab (Remicade), adalimumab (Humira) and certolizumab pegol (Cimzia). Also known as TNF inhibitors, these drugs work by neutralizing an immune system ...

  9. Treatment response and management of biologics in patients with ECD - Mayo Clinic

    These include tumor necrosis factor-alpha (TNFα) inhibitors (certolizumab, infliximab, adalimumab), anti-integrin agents (vedolizumab, natalizumab), and ...

  10. Ulcerative Colitis Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...